Suppliers and packages for generic ingredient: tofacitinib citrate
✉ Email this page to a colleague
tofacitinib citrate
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Pfizer | XELJANZ | tofacitinib citrate | SOLUTION;ORAL | 213082 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-1029-02 | 1 BOTTLE in 1 CARTON (0069-1029-02) / 240 mL in 1 BOTTLE (0069-1029-01) | 2021-02-08 |
| Pfizer | XELJANZ XR | tofacitinib citrate | TABLET, EXTENDED RELEASE;ORAL | 208246 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-0501-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-30) | 2016-03-07 |
| Pfizer | XELJANZ XR | tofacitinib citrate | TABLET, EXTENDED RELEASE;ORAL | 208246 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-0502-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30) | 2020-01-21 |
| Pfizer | XELJANZ XR | tofacitinib citrate | TABLET, EXTENDED RELEASE;ORAL | 208246 | NDA | U.S. Pharmaceuticals | 63539-501-14 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14) | 2016-03-07 |
| Pfizer | XELJANZ XR | tofacitinib citrate | TABLET, EXTENDED RELEASE;ORAL | 208246 | NDA | U.S. Pharmaceuticals | 63539-501-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30) | 2016-03-07 |
| Pfizer | XELJANZ XR | tofacitinib citrate | TABLET, EXTENDED RELEASE;ORAL | 208246 | NDA | U.S. Pharmaceuticals | 63539-502-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30) | 2020-01-21 |
| Pf Prism Cv | XELJANZ | tofacitinib citrate | TABLET;ORAL | 203214 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-1001-01 | 60 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01) | 2012-11-09 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
